Detalhe da pesquisa
1.
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.
Immunity
; 40(5): 669-80, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768348
2.
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.
Immunity
; 40(5): 657-68, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768347
3.
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
PLoS Pathog
; 11(8): e1005110, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267277
4.
Broad neutralization coverage of HIV by multiple highly potent antibodies.
Nature
; 477(7365): 466-70, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849977
5.
Anti-HIV B Cell lines as candidate vaccine biosensors.
J Immunol
; 189(10): 4816-24, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23066156
6.
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
J Virol
; 86(8): 4394-403, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22345481
7.
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
PLoS One
; 8(12): e80562, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24312481
8.
IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
MAbs
; 4(2): 153-81, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22453091
9.
Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.
Vaccine
; 29(16): 2910-7, 2011 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21338680
10.
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization.
J Virol
; 81(15): 8072-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17507469
11.
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.
J Gen Virol
; 87(Pt 9): 2571-2576, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16894195